From March 17 to 20, 2018, more than 800 IVD manufacturers at home and abroad and more than 30000 IVD medical testing related employees gathered in the mountain city to witness the prosperity of China's in vitro diagnosis industry. The 15th China (International) laboratory medicine and blood transfusion instruments and reagents Expo was grandly held in Chongqing International Convention and Exhibition Center. The event built a large platform for in vitro diagnosis with rich content and various forms with the theme of "commercial exhibition, academic communication and Industry Exchange".
In this exhibition, the company brought caris200 automatic chemiluminescence immunoanalyzer to n8-t20 booth. Caris200, relying on Wantai's strong R & D foundation of immune reagents, has an advantageous platform in infectious diseases and other fields. It is a key special project and a major project of in vitro diagnostic reagents in the "863 Plan" of the 12th Five Year Plan. With its advantages of high performance, high automation and international leading level, the platform has attracted many industry elites to inquire and communicate.
